MIRA Pharmaceuticals Stock (NASDAQ:MIRA)
Previous Close
$1.26
52W Range
$0.51 - $5.01
50D Avg
$1.34
200D Avg
$1.23
Market Cap
$21.47M
Avg Vol (3M)
$1.95M
Beta
6.73
Div Yield
-
MIRA Company Profile
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.